Average Co-Inventor Count = 7.72
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (48 from 329 patents)
2. Novartis Ag (14 from 3,923 patents)
3. Gilead Sciences, Inc. (2 from 919 patents)
4. Mirati Therapeutics, Inc. (2 from 38 patents)
5. Loxo Oncology, Inc. (1 from 34 patents)
6. Bristol-myers Squibb Compnay (3,681 patents)
62 patents:
1. 12338220 - Antiviral pyrazolopiridinone compounds
2. 12171739 - N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
3. 12071441 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
4. 11964989 - KRas G12D inhibitors
5. 11912715 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
6. 11780835 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
7. 11667613 - Antiviral pyrazolopyridinone compounds
8. 11629149 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
9. 11453683 - KRas G12D inhibitors
10. 11453677 - Tricyclic compounds useful to treat orthomyxovirus infections
11. 11174273 - Quinazoline analogs as receptor tyrosine kinase inhibitors
12. 11104676 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
13. 11098051 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
14. 11091486 - Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereof
15. 11072610 - Antiviral pyridopyrazinedione compounds